Published in TB and Outbreaks Week, January 15th, 2002
The current standard of care is treatment with amphotericin B (AmB) followed by fluconazole. The addition of Actimmune to the standard regimen showed a strong trend toward more rapid clearance of Cryptococcus fungus from cerebral spinal fluid (CSF), when compared with conventional antifungal therapy alone.
These data were presented December 18, 2001, at the 41st Annual...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.